Long-Term Follow-Up From the ORATORIO Trial of Ocrelizumab for Primary Progressive Multiple Sclerosis: A Post-Hoc Analysis From the Ongoing Open-Label Extension of the Randomised, Placebo-Controlled, Phase 3 Trial
ORATORIO
Oratorio
Easter Oratorio
The Oratorios of Handel